Information Technology Services
Compare Stocks
4 / 10Stock Comparison
DMRC vs CGNT vs VRNS vs NICE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Infrastructure
Software - Infrastructure
Software - Application
DMRC vs CGNT vs VRNS vs NICE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Information Technology Services | Software - Infrastructure | Software - Infrastructure | Software - Application |
| Market Cap | $188M | $793M | $3.37B | $5.78B |
| Revenue (TTM) | $34M | $377M | $660M | $2.95B |
| Net Income (TTM) | $-32M | $-5M | $-137M | $612M |
| Gross Margin | 61.6% | 70.9% | 78.1% | 66.4% |
| Operating Margin | -94.4% | 0.9% | -21.9% | 21.9% |
| Forward P/E | — | 46.9x | 242.2x | 8.7x |
| Total Debt | $4M | $36M | $572M | $164M |
| Cash & Equiv. | $10M | $113M | $202M | $379M |
DMRC vs CGNT vs VRNS vs NICE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 21 | May 26 | Return |
|---|---|---|---|
| Digimarc Corporation (DMRC) | 100 | 23.4 | -76.6% |
| Cognyte Software Lt… (CGNT) | 100 | 38.1 | -61.9% |
| Varonis Systems, In… (VRNS) | 100 | 46.9 | -53.1% |
| NICE Ltd. (NICE) | 100 | 41.7 | -58.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DMRC vs CGNT vs VRNS vs NICE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DMRC lags the leaders in this set but could rank higher in a more targeted comparison.
CGNT is the #2 pick in this set and the best alternative if momentum is your priority.
- +13.4% vs NICE's -40.4%
VRNS is the clearest fit if your priority is long-term compounding.
- 317.5% 10Y total return vs NICE's 50.7%
- 13.2% revenue growth vs DMRC's -11.7%
NICE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 0.72
- Rev growth 7.7%, EPS growth 43.0%, 3Y rev CAGR 10.5%
- Lower volatility, beta 0.72, Low D/E 4.2%, current ratio 1.55x
- Beta 0.72, current ratio 1.55x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.2% revenue growth vs DMRC's -11.7% | |
| Value | Lower P/E (8.7x vs 242.2x) | |
| Quality / Margins | 20.8% margin vs DMRC's -95.3% | |
| Stability / Safety | Beta 0.72 vs DMRC's 2.50, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +13.4% vs NICE's -40.4% | |
| Efficiency (ROA) | 11.8% ROA vs DMRC's -54.8%, ROIC 13.2% vs -53.6% |
DMRC vs CGNT vs VRNS vs NICE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DMRC vs CGNT vs VRNS vs NICE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NICE leads in 3 of 6 categories
CGNT leads 1 • DMRC leads 0 • VRNS leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NICE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NICE is the larger business by revenue, generating $2.9B annually — 86.9x DMRC's $34M. NICE is the more profitable business, keeping 20.8% of every revenue dollar as net income compared to DMRC's -95.3%. On growth, VRNS holds the edge at +26.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $34M | $377M | $660M | $2.9B |
| EBITDAEarnings before interest/tax | -$27M | $16M | -$135M | $845M |
| Net IncomeAfter-tax profit | -$32M | -$5M | -$137M | $612M |
| Free Cash FlowCash after capex | -$12M | $11M | $120M | $665M |
| Gross MarginGross profit ÷ Revenue | +61.6% | +70.9% | +78.1% | +66.4% |
| Operating MarginEBIT ÷ Revenue | -94.4% | +0.9% | -21.9% | +21.9% |
| Net MarginNet income ÷ Revenue | -95.3% | -1.2% | -20.7% | +20.8% |
| FCF MarginFCF ÷ Revenue | -36.8% | +3.0% | +18.1% | +22.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.9% | +15.5% | +26.9% | +9.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +52.5% | +173.6% | 0.0% | +56.5% |
Valuation Metrics
NICE leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, NICE's 6.6x EV/EBITDA is more attractive than CGNT's 83.9x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $188M | $793M | $3.4B | $5.8B |
| Enterprise ValueMkt cap + debt − cash | $182M | $715M | $3.7B | $5.6B |
| Trailing P/EPrice ÷ TTM EPS | -5.76x | -64.71x | -25.38x | 9.89x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 46.93x | 242.23x | 8.74x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.37x |
| EV / EBITDAEnterprise value multiple | — | 83.91x | — | 6.59x |
| Price / SalesMarket cap ÷ Revenue | 5.54x | 2.26x | 5.40x | 1.96x |
| Price / BookPrice ÷ Book value/share | 4.62x | 3.64x | 6.19x | 1.56x |
| Price / FCFMarket cap ÷ FCF | — | 23.59x | 24.99x | 8.22x |
Profitability & Efficiency
NICE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NICE delivers a 16.4% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-73 for DMRC. NICE carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to VRNS's 0.96x. On the Piotroski fundamental quality scale (0–9), NICE scores 7/9 vs DMRC's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -72.6% | -2.0% | -27.4% | +16.4% |
| ROA (TTM)Return on assets | -54.8% | -0.9% | -8.2% | +11.8% |
| ROICReturn on invested capital | -53.6% | -2.5% | -11.0% | +13.2% |
| ROCEReturn on capital employed | -57.6% | -1.8% | -14.0% | +16.1% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 5 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.11x | 0.16x | 0.96x | 0.04x |
| Net DebtTotal debt minus cash | -$6M | -$77M | $369M | -$216M |
| Cash & Equiv.Liquid assets | $10M | $113M | $202M | $379M |
| Total DebtShort + long-term debt | $4M | $36M | $572M | $164M |
| Interest CoverageEBIT ÷ Interest expense | — | 21.71x | -9.01x | — |
Total Returns (Dividends Reinvested)
CGNT leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VRNS five years ago would be worth $6,014 today (with dividends reinvested), compared to $2,803 for DMRC. Over the past 12 months, CGNT leads with a +13.4% total return vs NICE's -40.4%. The 3-year compound annual growth rate (CAGR) favors CGNT at 36.8% vs DMRC's -24.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +35.8% | +23.6% | -10.5% | -14.6% |
| 1-Year ReturnPast 12 months | -33.4% | +13.4% | -36.7% | -40.4% |
| 3-Year ReturnCumulative with dividends | -56.6% | +155.8% | +23.7% | -49.3% |
| 5-Year ReturnCumulative with dividends | -72.0% | -54.7% | -39.9% | -59.1% |
| 10-Year ReturnCumulative with dividends | -70.3% | -60.7% | +317.5% | +50.7% |
| CAGR (3Y)Annualised 3-year return | -24.3% | +36.8% | +7.3% | -20.2% |
Risk & Volatility
Evenly matched — CGNT and NICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
NICE is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than DMRC's 2.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CGNT currently trades 94.3% from its 52-week high vs VRNS's 44.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.50x | 1.27x | 0.95x | 0.72x |
| 52-Week HighHighest price in past year | $14.64 | $11.66 | $63.90 | $180.61 |
| 52-Week LowLowest price in past year | $4.07 | $6.29 | $19.70 | $94.89 |
| % of 52W HighCurrent price vs 52-week peak | +58.6% | +94.3% | +44.9% | +53.0% |
| RSI (14)Momentum oscillator 0–100 | 67.8 | 66.7 | 66.1 | 40.9 |
| Avg Volume (50D)Average daily shares traded | 222K | 496K | 2.3M | 631K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: DMRC as "Buy", CGNT as "Hold", VRNS as "Buy", NICE as "Buy". Consensus price targets imply 179.7% upside for DMRC (target: $24) vs -2.3% for CGNT (target: $11).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $24.00 | $10.75 | $36.00 | $150.88 |
| # AnalystsCovering analysts | 8 | 5 | 34 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 0 | 0 | — | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | +0.7% | +3.4% | +8.5% |
NICE leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CGNT leads in 1 (Total Returns). 1 tied.
DMRC vs CGNT vs VRNS vs NICE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DMRC or CGNT or VRNS or NICE a better buy right now?
For growth investors, Varonis Systems, Inc.
(VRNS) is the stronger pick with 13. 2% revenue growth year-over-year, versus -11. 7% for Digimarc Corporation (DMRC). NICE Ltd. (NICE) offers the better valuation at 9. 9x trailing P/E (8. 7x forward), making it the more compelling value choice. Analysts rate Digimarc Corporation (DMRC) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DMRC or CGNT or VRNS or NICE?
On forward P/E, NICE Ltd.
is actually cheaper at 8. 7x.
03Which is the better long-term investment — DMRC or CGNT or VRNS or NICE?
Over the past 5 years, Varonis Systems, Inc.
(VRNS) delivered a total return of -39. 9%, compared to -72. 0% for Digimarc Corporation (DMRC). Over 10 years, the gap is even starker: VRNS returned +317. 5% versus DMRC's -70. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DMRC or CGNT or VRNS or NICE?
By beta (market sensitivity over 5 years), NICE Ltd.
(NICE) is the lower-risk stock at 0. 72β versus Digimarc Corporation's 2. 50β — meaning DMRC is approximately 245% more volatile than NICE relative to the S&P 500. On balance sheet safety, NICE Ltd. (NICE) carries a lower debt/equity ratio of 4% versus 96% for Varonis Systems, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DMRC or CGNT or VRNS or NICE?
By revenue growth (latest reported year), Varonis Systems, Inc.
(VRNS) is pulling ahead at 13. 2% versus -11. 7% for Digimarc Corporation (DMRC). On earnings-per-share growth, the picture is similar: NICE Ltd. grew EPS 43. 0% year-over-year, compared to -31. 4% for Varonis Systems, Inc.. Over a 3-year CAGR, NICE leads at 10. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DMRC or CGNT or VRNS or NICE?
NICE Ltd.
(NICE) is the more profitable company, earning 20. 8% net margin versus -95. 3% for Digimarc Corporation — meaning it keeps 20. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NICE leads at 21. 9% versus -94. 4% for DMRC. At the gross margin level — before operating expenses — VRNS leads at 79. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DMRC or CGNT or VRNS or NICE more undervalued right now?
On forward earnings alone, NICE Ltd.
(NICE) trades at 8. 7x forward P/E versus 242. 2x for Varonis Systems, Inc. — 233. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DMRC: 179. 7% to $24. 00.
08Which pays a better dividend — DMRC or CGNT or VRNS or NICE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is DMRC or CGNT or VRNS or NICE better for a retirement portfolio?
For long-horizon retirement investors, NICE Ltd.
(NICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72)). Digimarc Corporation (DMRC) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NICE: +50. 7%, DMRC: -70. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DMRC and CGNT and VRNS and NICE?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: DMRC is a small-cap quality compounder stock; CGNT is a small-cap quality compounder stock; VRNS is a small-cap quality compounder stock; NICE is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.